BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260614
DTEND;VALUE=DATE:20260619
DTSTAMP:20260620T005854
CREATED:20260316T091256Z
LAST-MODIFIED:20260316T091256Z
UID:10024-1781395200-1781827199@thebiocalendar.com
SUMMARY:DIA 2026 Global Annual Meeting
DESCRIPTION:The DIA Global Annual Meeting is where life sciences professionals from industry\, regulatory agencies\, patients\, and academia come together to drive breakthroughs in healthcare — advancing science\, policy\, and patient outcomes worldwide.
URL:https://thebiocalendar.com/event/dia-2026-global-annual-meeting/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Annual Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T110000
DTEND;TZID=America/Los_Angeles:20260616T120000
DTSTAMP:20260620T005854
CREATED:20260519T191458Z
LAST-MODIFIED:20260522T082159Z
UID:10481-1781607600-1781611200@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update June 2026:   Cell Therapy
DESCRIPTION:In this session\, leading cell therapy CDMOs will break down how they support programs across development—from early process work through GMP manufacturing\, scale-up\, and commercial readiness—and where different approaches can reduce downstream risk or introduce it. \nThis is a focused look at who does what\, and where they fit—so you can evaluate partners with greater clarity and move forward with more confidence.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-june-2026-cell-therapy/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-OPCU-1280x720-CELL-THERAPY-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T110000
DTEND;TZID=America/Los_Angeles:20260616T120000
DTSTAMP:20260620T005854
CREATED:20260528T173411Z
LAST-MODIFIED:20260528T173411Z
UID:10549-1781607600-1781611200@thebiocalendar.com
SUMMARY:The Levers And Tradeoffs That Drive Process Productivity
DESCRIPTION:Increasing titers isn’t the only way to maximize process efficiency. Whether you’re optimizing an existing process or developing the next generation of biologics\, we can help you identify the levers that matter most. \nJoin us for an interactive discussion on the process decisions\, tradeoffs\, and operational realities shaping modern biologics manufacturing. Bioprocess Online’s Tyler Menichiello will moderate a conversation with two industry experts bringing firsthand experience in process development and biopharmaceutical manufacturing: \n• David Scherr\, Ph.D.\, Senior Scientist\, Bioprocessing Technologies and Engineering at AstraZeneca\n• Vadim Klyushnichenko\, Ph.D.\, VP\, Biopharmaceutical Development and Quality at Calibr-Skaggs Institute for Innovative Medicines \nScherr and Klyushnichenko will discuss where productivity gains are actually achieved and how teams are finding success by simplifying purification strategies and reducing chromatography steps. They will also explore how less obvious constraints (e.g.\, developability and facility fit) can shape productivity early and how complex molecules like bispecifics are redefining what process efficiency looks like. \nReserve your spot today.
URL:https://thebiocalendar.com/event/the-levers-and-tradeoffs-that-drive-process-productivity/
LOCATION:CA
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/26_06-BPOL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T130000
DTEND;TZID=America/Los_Angeles:20260616T140000
DTSTAMP:20260620T005854
CREATED:20260519T191645Z
LAST-MODIFIED:20260522T082135Z
UID:10485-1781614800-1781618400@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update June 2026: Cell Line Development
DESCRIPTION:In this session\, leading CDMO experts will break down the key decisions across host cell selection\, vector design\, and clone screening strategies\, and explain how those choices impact expression\, scalability\, and long-term manufacturability. \nThese presentations will highlight how different CDMO approaches can reduce downstream risk or introduce it\, as programs move from early development into tech transfer and commercial readiness. \nIf you are advancing a monoclonal antibody\, recombinant protein\, or next-generation biologic\, this session will help clarify what to evaluate early—and what to avoid.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-june-2026-cell-line-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-OPCU-1280x720-cell-line-scaled.png
END:VEVENT
END:VCALENDAR